Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Glioblastoma
IDH-wildtype disease that almost always recurs: EGFR, the blood-brain barrier and cell therapy attempts.
AACR Annual Meeting 2026
17–22 Apr 2026, San Diego · Cancer Research 86 (7_Supplement)
All 7,489 abstracts, including clinical trial (CT) and late-breaking (LB) abstracts, have Cancer Research supplement DOIs in Crossref.
Indexed in Crossref
135 abstracts matching glioblastoma from the meeting's journal supplement, fetched live from Crossref 2026-11-12 10:01 UTC. This is a keyword search, not the complete abstract book.
- 1055Assessing biomarker reproducibility for glioblastoma patient response stratificationChristopher M. Jannotta, C Zoe Linke, Charles A. Whittaker, Vikas Patil et al.
- LB107A novel short isoform of adhesion GPCR BAI3, originated from an alternative promoter, reverses the EMT process, and confers survival benefit in glioblastoma multiforme (GBM)Rashed Rezwan Parag, Virginea De Araujo Farias, Haifa A. Alsharif, Md Simul Bhuiya et al.
- 5990UBE3A and SV2A modulate GBM progression through MAPK pathway regulationLee Eunju, MIN-JEE KIM, Peter CW Lee
- 4634Pretreatment with pan-integrin inhibitor GLPG-0187 sensitizes GBM cells to radiationMaryam Ghandali, lanlan Zhou, Wafik S. El-Deiry
- 4805Investigating the interaction between GBM and perivascular niche using an engineered brain microenvironment modelSheridan Ke-Wing Fok, Hanrong Ye, Ahmad Khalil, Brendan Harley
- 2791
- 4875Modeling GBM-vasculature interaction on chipPromise Emeh, Alan Fetah, Jade Admiraal, Marleen Bokkers et al.
- 1270Immunotoxin GB13 Targets GBM and H3.3K27M DIPG with the activation of Golgi-to-ER retrograde transport pathways.Nanyun Tang, Yue Hao, Valerie DeLuca, Charles Caleb Shaffer et al.
- 2508New precision treatments for glioblastomaLateef Owolabi Anifowose, Zhi Sheng
- 7102Overcoming cytidine deaminase (CDA) mediated resistance via EO-4426 dual DNA-replication targeting: Implications for CDA-high solid tumors and mesenchymal GBMJeffrey Bacha, Denni M. Brown, Richard Daniels, Sarath Kanekal et al.
- 827Actin cytoskeleton modulation reprograms resistant GBM spheroids and GSCs, enhancing response to IR and temozolomide in vitro and in vivo.Yuli Thamires Magalhães, Viktor Kalbermatter Boell, Letícia Ramos Molica, Donna Joe et al.
- 1565Analyzing Tumor Treating Fields (TTFields) therapy concomitantly with checkpoint inhibitors in a GBM mouse modelSi Yeon Lee, Kwang Bog Cho, Caren Wu, Justin Liu et al.
- 1251Real-world evaluation of multimodal AI: Foundation model-driven multimodal AI for GBM, NSCLC, and PDAC.Aakash Gireesh Tripathi, Asim Waqas, Evan W. Davis, Jennifer B. Permuth et al.
- 3445Astrocytes reprogram radiation-resistant glioblastoma to reveal new therapeutic vulnerabilitiesRana Abdelgawad, Andrew Dhawan
- 4535Targeting LPAR1 as a potential therapeutic strategy for glioblastomaSatoshi Takagi, Sumie Koike, Ryohei Katayama
- 6915Investigating the role of the conserved notch pathway in glioblastoma cells.Larissa Barroso, Megan E. Keniry
- 1602
- 3344Pyk2 controls rab proteins by vesicle trafficking in glioblastoma cellsNeisha Marie Ramirez Serrano, Lilia Kucheryavykh
- 3288Spermine enhances oxidative phosphorylation independently of translation in glioblastomaAlexandra Carbone, Tim Horton, Ayush Rana, Scott Welford
- NG03
- 2979MAPK driven kinetochore instability as a biomarker and therapeutic vulnerability in glioblastomaJennifer DeLuca, Patrick J. Paddison
- 3077A novel MMP-targeting peptide suppresses glioblastoma metastasis by reducing MSI1 activityXian Liu, Liang-Ting Lin
- 6382Temozolomide co-encapsulated radioPDT nanoparticles possess effective cytotoxicity for the treatment of glioblastoma.Muhammad Rafiq, Deepak Dinakaran
- LB076Targeting suv39h1 epigenetic silencing to induce viral mimicry and suppress glioblastoma growthYi Sak Kim, Charles Spruck
- LB035The natural compound KH617: A safe and selective therapeutic agent targeting GBM metabolic reprogrammingChun-Jie Li, Xue Yang, Li-Tao Liu, Yun Feng et al.
- 3184HMGB1 mediates chemoresistance and tumor progression in glioblastoma: Implications for targeted therapySucharita Patra, Shreya Banerjee, Mahitosh Mandal
- 3368Metabolite-driven post-translational modifications regulate mitochondrial homeostasis in the glioblastoma microenvironmentZhongsheng You, Karrie Kiang, Gilberto Leung
- 5139A novel toll-like receptor antagonist lead for glioblastoma and pancreatic and breast cancerMilan Makale, Wolfgang Wrasidlo
- 6581
- 3222Identifying novel biomarkers for Saudi glioblastoma multiform using multi-omics approachAbdulmonem A. Alsaleh, Ahmed Aloraidi, Bahauddeen M. Alrfaei
- 6376Magnetoelectric MOFs for ferroptosis-driven and immune-enhanced glioblastoma therapy.Huiwen Lien, Shang-Hsiu Hu, Alan Yueh-Luen Lee
- LB486Origination and refinement of blood brain barrier spheroid model for glioblastoma therapy discoveryRyan Toedebusch, Christine Toedebusch, Randy Carney
- 4629Modeling pharmacokinetics and efficacy of the ATM inhibitor WSD0628 in GBM and melanoma metastasis PDX modelsAnn Catherine Mladek, Juhee Oh, Sneha Rathi, Lily Liu et al.
- 993From phenotypic screening to mechanistic insight: Rational discovery of chemosensitizers for glioblastomaLukas Gorecki, Lubica Muckova, Michaela Sadibolova, Ondrej Soukup
- 2900Activation of the cGAS-STING signaling pathway as an immunotherapeutic approach to glioblastomaLouise Leparc, Judit Sanchez Gil, Hiroaki Wakimoto
- 722Discovery of an evolutionarily conserved GPCR-like protein shaping glioblastoma cell networks.Jennifer Arcuri, Bruno Colon, Shraddha ChandThakuri, Daniel Isom
- 3306The role of DDR1 ectodomain shedding in glioblastoma radiation resistanceSophia Dunlap, Caitlin A. Harvey, Christopher D. Willey, Ahn Erin
- 7483Adhesion plasticity and bidirectional paracrine signaling cooperatively drive glioblastoma invasionAbhinaba Banerjee, Audrey Iwashita, Afsheen Banisadr, Frank Furnari et al.
- 4471
- 7195Blocking hERG1 enhances radiation sensitization in glioblastomaHannah E. Goen, Naya Ohuabunwa, Jonathan D. Rodgers Gochicoa, Tingting Huang et al.
- 7523A vascularized glioblastoma tumor spheroid model for studying tumor invasion and therapeutic responseAnagha Shreesha, Sheridan Ke-Wing Fok, Brendan Harley
- 7128The rise of YAP: A new hope in glioblastoma treatmentShuhan Cao, Ethan C. Wong, Gilberto K. Leung, Karrie M. Kiang
- 3342Mito-EV-driven mitochondrial transfer: A trigger for ferroptosis in glioblastomaJunbo Liao, Shuhan Cao, Ka Kit Gilberto Leung, Karrie. M Kiang
- 274Overcoming recombination in semi-replicating retroviral vectors: A novel double suicide gene therapy for glioblastoma.Soojin Kim, Moonkyung Kang, Yeon-Soo Kim
- 6612Targeting CPT-1-mediated fatty acid oxidation causes radiation sensitization in glioblastoma.Kenneth M. Austin, Tingting Huang, Todd Miller, Kelli B. Pointer
- 5987Dual targeting of Pyk2/FAK and MEK/ERK pathways enhances growth suppression in glioblastomaEmely Morales-Colon, Kevin A. Rosa- Gonzalez, Lilia Kucheryavykh
- 3416Functional heterogeneity of the human blood-tumor barrier phenotype induced by patient-derived glioblastoma spheroidsSrishti Kala, Luke M. Markowski, Moriah E. Katt
- 3286The Warburg hijack of myeloid immunity via mitochondrial dysregulation in glioblastomaChun Wai Aeon Kwok, Karrie Mei Yee Kiang, Gilberto Ka Kit Leung
- 3464Defining the role of CRK and CRKL in glioblastoma invasiveness: from cell culture to mouse modelsPiyanka Hettiarachchi, Neka Large, Taeju Peter Park
- 3307CD99 homophilic signaling between tumor-associated macrophages and glioblastoma cells regulates response to immunotherapyTongchao Jiang, Zilu Huang, Nan Li, Haishuang Sun et al.
- 7149The paradoxical role of SIRT1 in glioblastoma mediated by the tumor microenvironmentAnza Mnahal, Wanjun Tang, Bo Chen, Karrie Mei Kiang et al.
- 1944Hypermethylation of Sox21 masks its oncogenic role in glioblastoma.Shu-Huei Hsiao, Jui-Ming Sun, Tun-Wu Wang, Yu-Wei Leu et al.
- 3465An investigation into the role of AVIL, an actin-binding protein, in glioblastoma metabolismSummer Johnson, Robbie Cornelison, Adelaide Fierti, Martyna Glowczyk et al.
- 524Characterizing PTEN:Ki67 interactions and contribution to radioresistance in glioblastoma.Brandon Marshall Jones, Sejal Patel, Brett Taylor, Nidhi Nathwani et al.
- 6135Amyloid-β accumulation in glioblastoma is driven by vascular remodeling and APP-processing pathwaysFelix Y. Narvaez Irizarry, Alondra M. Bermudez Adorno, Lilia Kucheryavykh
- 7156Inhibition in the proliferation of pediatric glioblastoma facilitated with atypical protein kinase c inhibitorsShreejana Rimal, Grazielly Teodoro, Gaurab Raj Khanal, Mildred Acevedo-Duncan
- 7152ICA-1S targets PKC-ι and Cx43 to inhibit glioblastoma multiforme progressionGrazielly Teodoro, Shreejana Rimal, Wishrawana Sarathi Ratnayake, Gaurab Raj Khanal et al.
- 373Mitochondrial bioenergetics sustain ABCB1-driven temozolomide resistance in glioblastoma multiforme.Ashutosh Shrivastava, Manendra Singh Tomar, Chirag Kulkarni, Sreyanko Sadhukhan et al.
- 7509A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneityGrant De Jong, Fani Memi, Tannia Gracia, Olga Lazareva et al.
- 2924ζ-Stat inhibits glioblastoma multiforme progression by targeting PKC-ζ/Cx43 signaling and inducing senescence.Grazielly Teodoro, Shreejana Rimal, Wishrawana S. Ratnayake, Abigail Olatunji et al.
- LB228DPYSL2 mediates extracellular vesicle-driven reprogramming of the glioblastoma tumor microenvironmentMarissa Russo, Emily Norton, Weiwei Wang, Shreyartha Mukherjee et al.
- 4045Collagen binding enhances anti-CTLA4 therapy in recurrent glioblastomaLewis Barr, Jun Takei, Chuyi Wang, Opeyemi Iwaloye et al.
- LB143Modulation of G3BP1 influences the functional efficacy of CAR T cells against glioblastomaDonghyun Lee, Yoo-Shin Kim, Yogindra Vedvyas, Nathaniel Fredette et al.
- 7283Genomic landscape of IDH-wild-type glioblastoma in a patient treated with TNF-alpha inhibitor: Implications for risk stratification and therapeutic decision-makingSuryanarayan Mohapatra, Natarajan Ganesan
- 2200The mesenchymal state drives stemness and limits differentiation in glioblastoma.Emanuele Filiberto Rosatti, Denise Sighel, Anna Veronese, Toma Tebaldi et al.
- 6171Patient-derived pediatric glioblastoma models provide key insights into IDH1-driven drug resistanceStephen Friend, Matthew Graziano, Ruby E. Thamert, Heather Branscome et al.
- 5093Assessing the value of CBV in identifying early recurrence risk in glioblastomaMahsa Servati, Ziyu Fu, Aliya Anil, Chinmay Mokashi et al.
- 6676Spatial proteomics and AI-driven analysis uncover therapeutic landscapes within the glioblastoma microenvironmentNadine Nelson, Hoyin Lai, Sophie Struble, Richard A. Heil-Chapdelaine et al.
- 382Exploring the role of LONP1 in lon-traditional mechanisms of glioblastoma resistance.Shashi Jain, Dahlia A. Ordaz, Javier Lepe, Naomi Lomeli et al.
- 7435Spatial transcriptomics unveils tumor microenvironment changes in murine glioblastoma upon EGFRvIII suppressionFabio de Mello, David Eisenbarth, Feng Guo, Yamei Chen et al.
- 4300IND-enabling development of a novel STING agonist, IMGS-203, for the treatment of glioblastomaChristine Gagliardi, Paul Blezinger, Ahmad Salameh, Michael A. Curran et al.
- 237Selective Cytotoxicity of Base Excision Repair Inhibitor, TRC102, in DNA Damage Response Hyperactivated Glioblastoma.Shaunak Sathe, Qi Li, Jinkyu Jung, Peng Lu et al.
- 4665Programmable multivalent siRNA nanostructure rewires apoptosis by co-silencing MCL-1 and BCL-XL in glioblastomaQianhui Feng, Henry Lin, Yichen Yan, Rong Zheng et al.
- 7001Tumor-intrinsic suppression of phagocytosis by RRP1 (ribosomal RNA processing 1) in glioblastomaEshika Kudaravalli, Amr Elkholy, Mostafa Mohamed, Hasan Alrefai et al.
- 7017EMP2 is a potential immunotherapeutic target to modulate macrophage-induced phagocytosis in glioblastomaAmr Elkholy, Eshika Kudaravalli, Mostafa Mohamed, Hasan Alrefai et al.
- 3886A novel glioblastoma subtype classification using hallmark gene set signatures: Association between poor prognosis and TP53 downstream pathway.Yu Jin Kim, Jeongman Park, Woo Young Kwon, Jaejoon Lim et al.
- 7376HMGB2-mediated radioresistance of glioblastoma stem cellsSara Nalina Barcik Weissman, Cheol Park, Connor Mork, Khoi Huynh et al.
- 7783Collagen-binding IL-12 remodels immunosuppresive microenvironment and improves survival in recurrent glioblastomaOpeyemi Iwaloye, Jun Takei, Lewis Barr, Ken Furudate et al.
- 3462The scaffold protein CNK3 mediates pro-invasive signalling in glioblastomaGuillaume Serwe, David Kachaner, Thomas Perreault, Marc K. Saba-El-Leil et al.
- 7178Targeted modulation of the blood-tumor barrier enhances drug delivery and survival in glioblastoma modelsPhilippa C. Vaughn-Beaucaire, William Hawkins, Jasmine S. Clark, Jorge Luis Jimenez Macias et al.
- 4971Integrated spatial multiomic mapping of glioblastoma microenvironments via proteomic and transcriptomic profilingChia-Ying Lee, Arya Bahrami, Yi Cui, Megan Vandenberg et al.
- 6841Contrasting immune-tumor (predator-prey) dynamics in glioblastoma and melanoma to explain divergent responses to checkpoint blockade.Jodie Jepson, Elizabeth Owens, Elise Nackley, Helen Rizos et al.
- 6377Intranasal delivery of lipid-based nanoparticle encapsulating CXCR7 agonist improves PD-L1 blockade efficacy in glioblastoma.Chan-Chuan Liu, Yao-Wei Yeh, Cheng-Lin Wu, Tsung-Lin Tsai et al.
- 400Combinatorial treatment of glioblastoma with temozolomide (TMZ) plus 5-ethynyl-2'-deoxyuridine (EdU).Humeyra Kaanoglu, Yasemin Akyel, Adebimpe Adefolaju, Alain Valdivia et al.
- 5672PRMT5 inhibition enhances therapeutic vulnerability to Bcl-xL/Bcl-2 inhibitors in glioblastoma.Shumpei Onishi, Ashis Chowdhury, Jean-Paul Bryant, Dragan Maric et al.
- 2512A real time imaging based functional precision medicine (FPM) assay for glioblastomaThomas Quinn, Anand Panigrahy, Dina ElHarouni, Mariam A. Oumelloul et al.
- 7457IL-33-mediated control of myeloid immunity in glioblastoma progressionTala-Maria Mouannes, Shyam V. Menon, Peipei Zeng, Jianbo Zhang et al.
- 6632Trends in treatment and survival among patients with glioblastoma in the United States, 2000 to 2020: A population-based SEER analysis.Jianan Chen, Qiong Wu, Catherine Boldig, Rob J B Macaulay et al.
- 7410Antiviral therapy reverses CMV-induced oncogenic signaling and enhances NK cell cytotoxicity in glioblastoma with associated PD-L1 upregulation and iImmune modulationVida Tajiknia, Wafik S. El-Deiry, Connor Purcell, Sean E. Lawler
- LB296RNA structure-targeted inhibition suppresses glioblastoma growth in human cerebral organoidsMaria-Ancuta Jurj, Michael A. Attathikhun, Sanjay Kumar Singh, Meng Chen et al.
- 5545Collagen-binding anti-GITR antibody reshapes immunosuppressive microenvironment and prolongs survival in recurrent glioblastomaJun Takei, Chuyi Wang, Ken Furudate, Opeyemi Iwaloye et al.
- 6234Characterizing the competitive interactions between glioblastoma and oligodendrocyte progenitor cellsLindsey A. Dudley, Sunlan Lu, Beatrice O'Brien, Carol Watkins et al.
- LB032The natural compound KH617 reverses glioblastoma resistance to alkylating agents via MGMT modulationChun-Jie Li, Xue Yang, Ling-Min Lin, Qiao-Xin Tang et al.
- 4967Spatial divergence across glioblastoma multi-regional biopsies and corresponding neurosphere culturesRoberto Salatino, Jacob Geisberg, Arantxa Romero Toledo, Benjamin Oakes et al.
- 3000Tumor Treating Fields (TTFields) may weaken glioblastoma network connectivity, with implications for malignancyJulius Beichert, Jonas A. Kretz, Jena Kim, Xiaoyu Ma et al.
- 5265FLASH radiotherapy improves survival in mouse glioblastoma and spares circulating antigen reactive CD8+T-cellsYanxia Ma, Nhat Nguyen, Xuehong Gui, Edgardo Aguilar et al.
- 71916-thio-dG enhances standard-of-care radiation therapy by reprogramming the tumor microenvironment in glioblastoma multiformeAnthony Alexander Grichuk, Merve Yilmaz, Summer Barron, Priya Darbha et al.
- 5822Efficacy of targeted radionuclide therapy Using 131I-FAPi dimers labeled via tetrazine ligation in a human glioblastoma xenograft modelUmberto Maria Battisti, Marcel Martin, Vladimir Shalgunov, Filipe Elvas et al.
- 4868Modelling glioblastoma sensitivity to irradiation with a patient derived xenograft-derived 3D platformFu-Ju Chou, Annamaria Rapisarda, Marianna Zipeto, Michael Ritchie et al.
- 706Beyond a single core biopsy: Spatial genomic profiling improves therapeutic target detection in glioblastoma.Enmar Harfoush, Taylor Weiskittel, Mylan Blomquist, Dustin Grief et al.
- 4112Identification of NTRK missense mutations in glioblastoma multiforme: Insights from AACR Project GENIE and structural-functional analysesJehad A. Yasin, Muaath I. Alsufi, Ahmad Shawabkeh, Abdallah Al-Ramadi et al.
- 4956Spatial and vascular microenvironmental features predict tumor-infiltrating lymphocyte expansion in glioblastomaJodie Jepson, Kenan Zhang, Anna Corcoran, Elizabeth Owens et al.
- 851BMP inhibition is an effective treatment for targeting stem-like glioblastoma cell states.Davey (Cheng Zhe) Li, Michael Luo, Phuong U. Le, Maryam Safisamghabadi et al.
- LB001Dynamic circuit remodeling during glioblastoma progression: Depth-resolved electrophysiology and cortical imaging define network biomarkersMurat Yildirim, Tenesha Connor, Maryam Faisal, Omer Dinc et al.
- CT274Inhibiting 26S proteosome with sequential bortezomib and temozolomide garners 5 months prolonged survival in recurrent MGMT-negative GBM through amplified tyrosine kinase receptor signaling to avail NF-kB mechanistic target in NCT03643549 Phase IB/II trialDorota Goplen, Mohummad Aminur Rahman, Surendra Kumar, Marianne H. Hannisdal et al.
- 5919Dissecting gene regulation of cellular states in glioblastoma using single-cell multi-omicsMin Yang, Nicolas L. Gonzalez Castro, Alexander Jucht, Sophia Kovatsis et al.
- 4909Microbial stimuli differentially regulate astrocyte and glioblastoma cell phenotypesAriana N. De Jesus-Carrasquillo, Claudia M. Ramos-Lugo, Aliaha Serpa-Figueroa, Alondra Soto-Nieves et al.
- 3463Exploiting mechanisms of glioblastoma invasion to induce vulnerabilities that promote synergistic lethalityRifat S. Sajid, Lennart J. van Winden, Okty Abbasi Borhani, Evelyn R. Kamski-Hennekam et al.
- 2649Tumor endothelial cell and cancer cell targeting anti-PRND antibody-drug conjugate to treat hypervascular tumors such as glioblastoma and sarcomasByoungmo Kim, Ha Kyeong Lee, So-Young Choi, Sera Lee et al.
- 3341Focused ultrasound BBB opening yields distinct, tissue-specific extracellular vesicle profiles for glioblastoma liquid biopsyAndrew Thede, Zehra Demir, Khondamir Imomnazarov, Stefanyda Maslova et al.
- 3401Modeling the multicellular blood-brain barrier with a PDX-derived glioblastoma microenvironment: comparing human and mouse biochip systems for tumor heterogeneity and drug responseMichelle Zimmer, Amélie Paillereau, Thomas Sommermann, Lars Winkler et al.
- 3283Metabolic crosstalk between fatty acid oxidation and glycolysis underlies glioblastoma viabilityLola Martinez Ibarguren, Fiorella Orsini Zanetti, Sofia Paz Osorio Rencoret, Maria Florencia Arbe et al.
- 5840The development of minocycline-loaded microparticles and injectable alginate scaffolds composites to prolong release for the treatment of glioblastomaFlorestella Rivera, Dorina A. Madrid, Samantha C. Davila, Serenade Trevino et al.
- 1293A multimodal AI framework integrating spatial omics and radiomics for recurrence prediction in glioblastoma.Julia Louw, Tarak N. Nandi, Evan Calabrese, Roger E. Mclendon et al.
- 805Fluorescence-guided multi-sampling and spatial multi-omics reveal functional lipid vulnerabilities in glioblastoma.Adele-Asia Ponzoni, Evangelos Liapis, Lea Anne T. Maristela, Elizabeth E. Ginalis et al.
- 6020Cargo profiling of extracellular vesicles from senescent glioblastoma identifies small nucleolar RNAs as candidate liquid biomarkers for therapy-induced senescence.Valerie DeLuca, Nathaniel Hansen, Priya Digumarti, Nanyun Tang et al.
- 3454Dynamic alteration of ANXA2 expression as a predictor of response to neoadjuvant bevacizumab in newly diagnosed glioblastomaTaketo Ezaki, Ryota Tamura, Yohei Yamamoto, Jun Takei et al.
- 2918Agonist activation of RIG-I+tumor associated macrophages enhances anti-tumor immunity and therapeutic response in glioblastomaHan Xu, Sungwoon Lee, Felipe Saceanu Leser, Olga Federova et al.
- 694Spatially resolved genomics reveals evolutionary modes and imaging correlates in glioblastoma.You Jin Song, Yelyzaveta Miller-Michlits, Karl-Heinz Nenning, Christoph Bock et al.
- CT071Phase I/II study of the anti-P-selectin antibody crizanlizumab for newly-diagnosed unmethylated glioblastomaAnne Krinsky, Anshika Katyal, Opal Avramoff, Yulia Liubomirski et al.
- 5878Tumor Treating Fields remain effective in therapy-resistant glioblastoma with kinome shifts revealing novel therapeutic opportunitiesTaylor Lynn Schanel, Amber Jones, Rhea Pandit, Johsua C. Anderson et al.
- 1918CRISPR screening in human iPSC-derived glioblastoma models reveals RNA-binding protein dependencies associated with TERT promoter mutation.Christopher C. Chie, Daisuke Kawauchi, Shunichiro Miki, Nicholas O. Stevers et al.
- 7193Short exposure to TTFields potentiates radiation response in glioblastoma via downregulation of DNA repair pathwaysAnat Klein-Goldberg, Tali Voloshin, Aviv Meir, Efrat Zemer-Tov et al.
- 3930Developing a prognostic gene expression biomarker for re-irradiation in recurrent glioblastoma.Brooke C. Braman, William C. Chen, Radhika Mathur, Akshara Vykunta et al.
- 7767Spatial profiling of the tumor immune microenvironment following oncolytic herpes simplex virus treatment in glioblastomaSophia A. Paxton, Corinne H. Strawser, Lakshmi Prakruthi Rao Venkata, Elizabeth A. Garfinkle et al.
- 388DYRK1A-mediated quiescence establishes a therapeutically-resistant reservoir for glioblastoma recurrence.Ameesha Paliwal, Kevin Faust, Okty Abbasi Borhani, Rifat S. Sajid et al.
- 4784Galectin-1 as a central regulator of angiogenesis and metabolic reprogramming in glioblastomaLuisina B. Ripari, Joaquin P. Merlo, Mariana B. Vera, Olivia Morris-Hanon et al.
- CT041Investigator-initiated phase I trial of an oligonucleotide therapeutic targeting long noncoding RNA TUG1 for recurrent glioblastomaRyuta Saito, Fumiharu Ohka, Yohei Mineharu, Makoto Ohno et al.
- CT109A phase 0/1 study of PRMT5 inhibitor BMS-986504 in recurrent glioblastoma participants with MTAP deletionNader Sanai, Shwetal Mehta, Artak Tovmasyan, Jocelyn Harmon et al.
- 5820Biodistribution analysis of Leutetium-177 radiopharmaceuticals in mammary, prostate, and glioblastoma models using Alpha-SPECT Mini and gamma countsKathryn R. Meshaw, William F. Durham, Karsten E. Fynboe, Tyler Rowe et al.
- 816Spatial metabolic gradients drive epigenetic reprogramming in human glioblastoma.Sankha Subhra Chakrabarty, Yilin Xu, Shannon Coy, Jia-Ren Lin et al.
- 2207The impact of tumor treating fields (TTFields) on the transcriptome and the secretome of cancer stem-like cells isolated from the sub-ventricular zone of glioblastoma patients.Rachel B. Sidebottom, Antonia E. Sajche Sapon, Yamhilette Licon-Munoz, Christian A. Bowers et al.
- 7530Comparative analysis of therapy responses and stem cell marker expression in glioblastoma neurospheres verus monolayer cultures using imaging, cytotoxicity assays, and flow cytometryDaniel S. Costa, Joseph P. Kolb, Olivia Mankos, Karsten E. Fynboe et al.
- 809Spatially resolved multiomics profiling of glioblastoma reveals molecular signatures of neuropathology and immuno-oncology architecture using CosMx SMI.Yi Cui, Claire Williams, Chia-Ying Lee, Chi Phan et al.
- 6975Endogenous retrovirus-derived neoantigens enable a personalized cancer vaccine strategy for glioblastomaMegan Campbell Benz, Kenan Zhang, David M. Ashley, Christian Garde et al.